Dr. Richard Page answers the question: 'Which Defibrillator Is Right For Me?' — -- Question: I have heard there are special types of defibrillators. How do I know which one is best for me? Answer ...
Background:Since the 2009 revised advisory statement regarding Sprint Fidelis® Defibrillator Lead failure rates (Medtronic Inc., Minneapolis, MN, USA), there has been a significant increase in ...
Please provide your email address to receive an email when new articles are posted on . DENVER — Patients with indications for implantable cardioverter defibrillators and wide QRS durations derived no ...
LOS ANGELES (March 8, 2002) – Patients who suffer from advanced congestive heart failure and heart rhythm abnormalities may qualify to participate in one of two research trials now underway at ...
CHICAGO—Cardiac resynchronization therapy with defibrillators (CRT-D) is appropriate for patients who have left ventricular dysfunction and require chronic ventricular pacing, based on the findings of ...
Doctors discovered Roling's heart muscle was weak and wasn't pumping enough blood to meet his body's needs. He tried taking medication to correct his condition, but the pills didn't work well. He was ...
The University of Pittsburgh Medical Center has implanted the area’s first biventricular pacemaker/defibrillator that also monitors fluid build up in the heart and lungs, which is a primary indicator ...
Should surgeons implant a defibrillator in a 99-year-old patient's heart? This question, which might have seemed academic years ago, is becoming increasingly relevant as patients live longer and ask ...
SIOUX CITY -- Before Fred Roling had a defibrillator surgically implanted in his chest, he was frequently short of breath and felt sluggish. Doctors discovered the then 69-year-old Remsen, Iowa, man's ...
What are the indications for biventricular pacing? Biventricular pacing is an excellent option for certain patients with advanced heart failure. Also known as “cardiac resynchronization therapy”, ...
In total, 621 Sprint Fidelis® leads were followed by our physician group during the period from May 2004 through January 2010 with an average follow-up of 32 ± 16 months (see Table I). The average ...